An Orally Bioavailable Pyrrolinone Inhibitor of HIV-1 Protease:  Computational Analysis and X-ray Crystal Structure of the Enzyme Complex

We have described several potent inhibitors of the HIV-1 protease, based on the novel 3,5-linked bispyrrolinone scaffold which we developed to mimic the peptidal beta -strand/ beta -sheet structural motif. Our most active bispyrrolinone (IC sub(50) 1.3 nM, CIC sub(95) 800 nM) was not orally bioavail...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry Vol. 40; no. 16; pp. 2440 - 2444
Main Authors: Smith, Amos B, Hirschmann, Ralph, Pasternak, Alexander, Yao, Wenquing, Sprengeler, Paul A, Holloway, M. Katharine, Kuo, Lawrence C, Chen, Zhongguo, Darke, Paul L, Schleif, William A
Format: Journal Article
Language:English
Published: Washington, DC American Chemical Society 01-08-1997
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have described several potent inhibitors of the HIV-1 protease, based on the novel 3,5-linked bispyrrolinone scaffold which we developed to mimic the peptidal beta -strand/ beta -sheet structural motif. Our most active bispyrrolinone (IC sub(50) 1.3 nM, CIC sub(95) 800 nM) was not orally bioavailable in dogs, reflecting either nonabsorption from the gastrointestinal tract, first-pass metabolism in the liver, or excretion into the bile. The relatively high molecular weight of 735 may account for the poor oral bioavailability. We therefore sought to design and synthesize monopyrrolinone inhibitors of HIV-1 protease with molecular weights <600.
Bibliography:istex:0FB48AE4290A93545C8FAF9D155F6C78C50E097A
ark:/67375/TPS-03FMF3QF-C
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-2623
1520-4804
DOI:10.1021/jm970195u